| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |